Human papillomavirus 16 in the blood of women treated for cervical cancer.
In the present paper we study the behaviors of HPV 16 DNA in the blood of women during oncological treatment. Disappearance of HPV from the blood depends on the clinical Stage of cancer. It is possible that HPV remaining in the blood for a long time after oncological treatment might be some marker showing that the cancer tissue was not completely removed. There is some suggestion that detecting HPV in the cervix or in the blood of women without morphological lesions but with CIN in the past might indicate higher risk of cervical cancer recurrence.